Authors
Loading...
Randomized trial shows dexmedetomidine causes QTc prolongation in end-stage renal disease, highlighting arrhythmia risk.
Pulipaka et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: